Sat, 30 June 2012
Environmental, health and safety auditing of pharmaceutical facilities handling highly potent compounds
In this presentation, Dean M. Calhoun, CIH, with certification in industrial hygiene by the American Board of Industrial Hygiene (ABIH) discusses the key concepts and principles that need to be considered when auditing biotechnology and pharmaceutical facilities for potent compound safety issues. His talk was presented at the World Highly Potent Active Pharmaceutical Ingredient Summit in Philadelphia, PA in June of 2012. If you have any questions regarding potent compound safety, EHS auditing, occupational toxicology or industrial hygiene, please contact Affygility Solutions.
Tue, 31 January 2012
Nanotechnology and the Pharmaceutical Industry - an interview with Don Ewert of OSO Biopharmaceuticals.
Hello everybody and welcome back to another episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safety programs to the next level.
I’ll briefly cover what we talked about last time in episode number 17
And finally, we’ll discuss upcoming events and happenings of importance to environmental, health and safety professionals in the BioPharma Industry.
So, without further delay, let’s go ahead get started. Last time in Episode number 17 we discussed the topic of “Containment Validation and Surrogate Monitoring.” In that Podcast, Matt Meiners, Laboratory Services Manager for Bureau Veritas and I discussed what is surrogate monitoring, some of the key factors to consider when selecting a surrogate compound, and finally, what are some of the common mistakes that occur when performing containment validation and surrogate monitoring. It was a great interview, and I appreciate Matt taking the time out of his busy schedule to participate. If that’s something that may interest you, I would suggest that you go back and listen to Episode 17.
Alright, let’s now move on to our main topic for today which is an interview with Don Ewert, Environmental, Health and Safety Manager on nanotechnology. I should mention ahead of time, that this section of the podcast was recorded on January 19th, 2012 via Skype. There is a few instances where we have a Skype garble moment, so I do apologize in advance for that. So without further delay, here we go.
The next event that I would like to mention is the annual Society of Toxicology conference to be held on March 11th through 15th in San Francisco. Affygility Solutions won’t be exhibiting at this conference, but our Senior Toxicologist, Joe Nieusma, may be attending. If you would like more information on this conference go to the Society of Toxicology’s website at sot.org
That does it for this week’s show. We look forward to having you listen in next time.
About Affygility Solutions. Affygility Solutions provides environmental, health and safety software and services to the pharmaceutical, biotechnology, and medical device industry.